fluorobenzenes has been researched along with Cirrhosis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balligand, JL; Beauloye, C; Hamelet, J; Herijgers, P; Hermida, N; Hilfiker-Kleiner, D; Horman, S; Markl, A; Noppe, G; Van Assche, T; van Bilsen, M; Vanderper, A | 1 |
| Li, WH; Ma, YX; Xie, Q | 1 |
| Gökçe, A; Gökçe, EC; Gürer, B; Kahveci, R; Ozevren, H; Turkoglu, E | 1 |
| Guo, M; Huang, D; Li, JB; Li, S; Wang, FB; Wei, M; Yan, ML; Yu, T | 1 |
| Bianchi, P; Calise, D; Escourrou, G; Galinier, M; Guilbeau-Frugier, C; Lairez, O; Mialet-Perez, J; Ordener, C; Parini, A; Pizzinat, N; Roncalli, J; Seif, I; Spreux-Varoquaux, O | 1 |
| Chang, HJ; Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Lee, HW; Oh, BH; Park, YB; Sohn, DW | 1 |
| Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Song, JK | 1 |
| McDaniel, MC; Samady, H | 1 |
| Ferrannini, E; Madec, S; Rossi, C; Salvati, A; Santini, E; Solini, A | 1 |
| Garcia-Garcia, HM; Okamura, T; Serruys, PW; Shin, ES | 1 |
| Altamirano, L; Docherty, NG; García, IM; Manucha, W; Mazzei, LJ | 1 |
| Du, QJ; Ge, JB; Gong, H; Hu, K; Li, H; Qiu, ZH; Sun, AJ; Wu, CN; Zhang, WB; Zhao, G; Zou, YZ | 1 |
| Chai, HT; Chang, HW; Chang, LT; Chen, YT; Chung, SY; Ko, SF; Leu, S; Lin, KC; Sun, CK; Yen, CH; Yip, HK | 1 |
| Antonioli, L; Aydinoglu, F; Bernardini, N; Blandizzi, C; Colucci, R; Duranti, E; Fornai, M; Ippolito, C; Rugani, I; Segnani, C; Taddei, S; Virdis, A | 1 |
| Chen, CH; Chen, TH; Chen, YC; Cheng, CY; Hsu, YH; Sue, YM; Tsai, WL | 1 |
| Brown, L; Hoey, A; Levick, S; Loch, D | 1 |
| Cooper, SA; Ferrario, C; Habibi, J; Hayden, MR; Muniyappa, R; Qazi, MA; Sowers, JR; Stump, C; Thyfault, J; Tramontano, A; Whaley-Connell, A | 1 |
| Abbate, M; Banfi, C; Bellosta, S; Brioschi, M; Canavesi, M; Gelosa, P; Gianella, A; Guerrini, U; Mussoni, L; Nobili, E; Remuzzi, G; Rottoli, D; Sironi, L; Tremoli, E; Zoja, C | 1 |
1 trial(s) available for fluorobenzenes and Cirrhosis
| Article | Year |
|---|---|
Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
Topics: Aged; Calcinosis; Coronary Angiography; Coronary Artery Disease; Female; Fibrosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Necrosis; Predictive Value of Tests; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; User-Computer Interface | 2009 |
17 other study(ies) available for fluorobenzenes and Cirrhosis
| Article | Year |
|---|---|
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Topics: Actins; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Collagen Type I; Diastole; Disease Models, Animal; Enzyme Activation; Fibroblasts; Fibrosis; Fluorobenzenes; Heart Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Procollagen; Pyrimidines; Rats; Receptors, LDL; Recovery of Function; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Time Factors; Transfection; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1 | 2013 |
Evaluation of topical application and systemic administration of rosuvastatin in preventing epidural fibrosis in rats.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cicatrix; Disease Models, Animal; Epidural Space; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intubation, Gastrointestinal; Laminectomy; Male; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1 | 2015 |
Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Fluorobenzenes; Human Umbilical Vein Endothelial Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Infarction; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rosuvastatin Calcium; Sulfonamides; Vascular Endothelial Growth Factor A | 2015 |
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.
Topics: Animals; Aorta; Blood Pressure; Cardiomegaly; Fibrosis; Fluorobenzenes; Gene Deletion; Gene Expression Regulation; Heart Ventricles; Ketanserin; Mice; Mice, Knockout; Monoamine Oxidase; Myocardium; Piperidines; Pressure; Receptors, Serotonin; Serotonin; Stress, Physiological; Ultrasonography | 2009 |
Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Topics: Animals; Blood Pressure; Collagen; Disease Progression; Fibrosis; Fluorobenzenes; Heart; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Organ Size; Pyrimidines; Random Allocation; Rats; Rats, Inbred Dahl; Rosuvastatin Calcium; Sulfonamides | 2009 |
Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
Topics: Calcinosis; Coronary Artery Disease; Fatty Acids, Monounsaturated; Fibrosis; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Necrosis; Observer Variation; Predictive Value of Tests; Pyrimidines; Radiography; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; User-Computer Interface | 2009 |
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Topics: Angiotensin II; Cells, Cultured; Extracellular Matrix; Fatty Acids, Nonesterified; Fibrosis; Fluorobenzenes; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mesangial Cells; Metalloproteases; Pyrimidines; RNA, Small Interfering; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2011 |
Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Necrosis; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Calcification | 2012 |
Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.
Topics: Animals; Apoptosis; Bone Morphogenetic Protein 7; Cadherins; Female; Fibrosis; Fluorobenzenes; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Pyrimidines; Rats; Rats, Inbred WKY; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1; Ureteral Obstruction; WT1 Proteins | 2012 |
The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Fibrosis; Fluorobenzenes; Forkhead Transcription Factors; Hypertension; Hypertrophy; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; Protein Kinase C; Protein Kinase C beta; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Survivin; Ventricular Remodeling | 2012 |
Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.
Topics: Adenine; Animals; Biomarkers; Blood Urea Nitrogen; Body Weight; Creatinine; Cytoprotection; Disease Models, Animal; Endothelial Cells; Environmental Pollutants; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phenols; Protein Kinase C; Proteinuria; Pyrimidines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Time Factors | 2012 |
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.
Topics: Angiotensin II; Animals; Atherosclerosis; Cyclooxygenase 1; Disease Models, Animal; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Extracellular Matrix; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mechanical Phenomena; Membrane Proteins; Mesenteric Arteries; NADPH Oxidase 4; NADPH Oxidases; Phosphorylation; Protein Processing, Post-Translational; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Vascular Resistance; Vasodilation | 2013 |
Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E2 in rat renal tubular cells.
Topics: Animals; Cell Line; Dinoprostone; Epoprostenol; Fibrosis; Fluorobenzenes; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Pressure; Pyrimidines; Rats; Rosuvastatin Calcium; Sulfonamides | 2013 |
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Desoxycorticosterone; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy; Male; Myocardium; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sodium Chloride, Dietary; Sulfonamides; Ventricular Remodeling | 2006 |
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Female; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Glycoproteins; Mice; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Renin; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2007 |
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
Topics: Actins; Animals; Blood Pressure; Blotting, Western; Collagen; Disease Progression; Fibrinogen; Fibrinolysin; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microscopy, Electron; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Podocytes; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides | 2007 |